Pfizer Begins a Phase 1/2 Study to Evaluate Respiratory Syncytial Virus (RSV) Vaccine Pharmaceutical Investing
Acceleron Announces Initiation of PULSAR Phase 2 Trial of Sotatercept in Pulmonary Arterial Hypertension Pharmaceutical Investing
XBiotech Announces First Patient in Phase 2 Study Evaluating MABp1 in Patients with Atopic Dermatitis Biotech Investing
BioCorRx Announces Grant Submission to the National Institutes of Health for BICX102 Pharmaceutical Investing
CytomX Therapeutics Announces FDA Clearance of Investigational New Drug Application for CX-2029, a CD71-Directed Probody Therapeutic Pharmaceutical Investing
Aileron Therapeutics Announces Publication of ALRN-6924 Nonclinical Data in T-cell Lymphomas by Researchers at Dana-Farber Cancer Institute Pharmaceutical Investing
Agile Therapeutics Provides Regulatory Update on Twirla for the Prevention of Pregnancy Pharmaceutical Investing
“We’re Financially Prudent,” Says CFO and President of Knight Therapeutics Samira Sakhia Pharmaceutical Investing
LYRICA (pregabalin) Oral Solution CV Phase 3 Trial in Pediatric Epilepsy Meets Primary Endpoint Pharmaceutical Investing
